Relief of dyspeptic symptoms by colloidal bismuth subcitrate in Helicobacter-negative and -positive patients: Results of a study in general practice

Netherlands Journal of Medicine

Volumn 57, Issue 6, 2000, Pages 209-214

  Weusten, Bas L A M ^a   Sicking, Paul J M ^b   Otten, Henk Willem ^c   Smout, André J P M ^a   Otten, Marten H ^a  

^a EEMLAND HOSPITAL   (Netherlands)

^b Yamanouchi Pharma ^*

^c Department of Gastroenterology   (Netherlands)

Author keywords

Bismuth subcitrate; Dyspepsia; General practice; Helicobacter pylori

Indexed keywords

BISMUTH CITRATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; DOSE RESPONSE; DYSPEPSIA; ERADICATION THERAPY; FEMALE; GENERAL PRACTICE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; SCORING SYSTEM; STOMACH MUCOSA; UPPER GASTROINTESTINAL TRACT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTACIDS; DYSPEPSIA; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PATIENT SATISFACTION; PROBABILITY; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0033659756     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(00)00073-5     Document Type: Article

References (34)

1. Management of dyspepsia: Report of a working party
2. Prevalence of symptoms of dyspepsia in the community
3. Dyspepsia: A dilemma for doctors
4. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study
5. Helicobacter pyloriinfection and non-ulcer dyspepsia: The effect of treatment with colloidal bismuth subcitrate
6. A prospective comparison of symptoms and five diagnostic tests in patients with Helicobacter pylori positive and negative dyspepsia
7. Triple therapy for Helicobacter pylori in nonulcer dyspepsia
8. Is Helicobacter pylori the cause of dyspepsia
9. Long term prospective study of Helicobacter pylori in non-ulcer dyspepsia
10. A quantitative analysis of symptoms of non-ulcer dyspepsia as related to age, pathology, and Helicobacter infection
11. Helicobacter pylori infection in non-ulcer dyspeptic and ulcer patients. Determinants and consequences in 'real life'
12. Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study
13. Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: A prospective controlled assessment
14. Lack of effect ot treating Helicobacter pylori infection in patients with nonulcer dyspepsia
15. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia
16. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia
17. Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with twelve months follow up
18. Colloidal bismuth subcitrate in non-ulcer dyspepsia
19. Diagnosis of Helicobacter pylori infection by using pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies
20. Evaluation of commercially available Helicobacter pylori serology kits: A review
21. Helicobacter treatment with quadruple therapy in primary health care for patients with a history of ulcer disease
22. Helicobacter pylori treatment instead of maintenance therapy for peptic ulcer disease: The effectiveness of case-finding in general practice
23. Gastritis and Campylobacter pylori in healthy, asymptomatic volunteers
24. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons
25. Non-ulcer dyspepsia: Potential causes and pathophysiology
26. Non-ulcer dyspepsia and short-term DE-NOL therapy: A placebo-controlled trial with particular reference to the role of Campylobacter pylori
27. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia
28. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori
29. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: A double blind placebo controlled trial with colloidal bismuth subcitrate
30. Non-ulcer dyspepsia: Does Helicobacter pylori matter?
31. Mucosal defences and gastro-duodenal disease
32. Gastroprotective and ulcer healing properties of bismuth salts
33. Effect of bismuth subcitrate on amphibian gastroduodenal bicarbonate secretion